Article Text

Download PDFPDF
High platelet reactivity to multiple agonists during aspirin and clopidogrel treatment is indicative of a global hyperreactive platelet phenotype

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Funding This study was partly supported by grants from the Institute of the Health Sciences, Gyeongsang National University and Sinai Hospital Baltimore.

  • Competing interests Dr Jeong received honoraria from Sanofi-Aventis, Daiichi Sankyo Inc. and Otsuka. Dr Gurbel received research grants, honoraria and consultant fees from Haemoscope, AstraZeneca, Schering-Plough/Merck, Medtronic, Lilly/Daiichi Sankyo Inc., Sanofi-Aventis/Bristol Myers, Portola, Boston Scientific, Bayer, Novartis, Accumetrics, Boehringer Ingelheim and Johnson & Johnson.

  • Patient consent Obtained.

  • Ethics approval Ethics approval was obtained from the Gyeongsang National University Hospital institutional review board.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles

  • PostScript
    Nicoline J Breet Jochem W van Werkum Heleen J Bouman Johannes C Kelder Ankie M Harmsze Christian M Hackeng Jurriën M ten Berg